BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 28556516)

  • 21. Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step.
    Chui MH
    Int J Cancer; 2013 Apr; 132(7):1487-95. PubMed ID: 22833228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation.
    Iser IC; Pereira MB; Lenz G; Wink MR
    Med Res Rev; 2017 Mar; 37(2):271-313. PubMed ID: 27617697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
    Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
    J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
    Chockley PJ; Keshamouni VG
    J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered expression of E-Cadherin-related transcription factors indicates partial epithelial-mesenchymal transition in aggressive meningiomas.
    Wallesch M; Pachow D; Blücher C; Firsching R; Warnke JP; Braunsdorf WEK; Kirches E; Mawrin C
    J Neurol Sci; 2017 Sep; 380():112-121. PubMed ID: 28870549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
    Li H; Xu F; Li S; Zhong A; Meng X; Lai M
    Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression.
    Fedele M; Sgarra R; Battista S; Cerchia L; Manfioletti G
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET.
    Goossens S; Vandamme N; Van Vlierberghe P; Berx G
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):584-591. PubMed ID: 28669750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells.
    Shenoy AK; Jin Y; Luo H; Tang M; Pampo C; Shao R; Siemann DW; Wu L; Heldermon CD; Law BK; Chang LJ; Lu J
    J Clin Invest; 2016 Nov; 126(11):4174-4186. PubMed ID: 27721239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
    Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
    Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks.
    Vaquero J; Guedj N; Clapéron A; Nguyen Ho-Bouldoires TH; Paradis V; Fouassier L
    J Hepatol; 2017 Feb; 66(2):424-441. PubMed ID: 27686679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
    Fuxe J; Karlsson MC
    Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
    Hamilton G; Rath B
    Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer.
    Alkatout I; Wiedermann M; Bauer M; Wenners A; Jonat W; Klapper W
    Exp Mol Pathol; 2013 Feb; 94(1):168-73. PubMed ID: 22985790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
    Garg M
    Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Emerging Roles of RUNX Transcription Factors in Epithelial-Mesenchymal Transition.
    Voon DC; Thiery JP
    Adv Exp Med Biol; 2017; 962():471-489. PubMed ID: 28299674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelial-Mesenchymal Transition in Acute Leukemias.
    Varisli L; Vlahopoulos S
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The epithelial-mesenchymal transition in cancer: a potential critical topic for translational proteomic research.
    Bottoni P; Isgrò MA; Scatena R
    Expert Rev Proteomics; 2016; 13(1):115-33. PubMed ID: 26567562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond.
    Nakazawa M; Kyprianou N
    J Steroid Biochem Mol Biol; 2017 Feb; 166():84-90. PubMed ID: 27189666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
    Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
    Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.